NEW YORK (GenomeWeb) – Molecular diagnostics firm AutoGenomics has refiled for an initial public offering, less than one year after it pulled earlier plans to go public.

The Vista, Calif.-based firm filed a Form S-1 with the US Securities and Exchange Commission on Tuesday, saying it intends to offer a maximum aggregate of $60 million of its shares. It has not priced its stock or said how many shares it intends to offer. The company plans to list on the Nasdaq Global Market under ticker symbol "AGMX."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.